Article
26 Jun 2023
Proposed Medicaid Rebate Rule "Updates" Reflect Significant Program Changes
AUTHORS CONTENT
Article
14 Dec 2020
Long-Awaited Issuance Of Section 340B ADR Final Rule
Article
26 Mar 2020
CMS Rolls Out New Medicare Part D "Senior Savings Model" Designed To Drive Down Insulin Copayments
Article
27 Feb 2020
United States Federal And State Rules And Regulations During Public Health Emergencies: Navigating Novel Coronavirus
Article
07 Feb 2019
OIG's Proposed Drug Pricing Safe Harbor Amendments: "Hot Takes"
Article
24 Jan 2019
Prescription Drug Purchasing Initiative In California Raises Legal Questions
Article
14 Sep 2018
OIG Issues Request For Information On Federal Anti-Kickback And Beneficiary Inducement Issues
Article
25 Jul 2018
OIG Moving Ahead On Changes To Anti-Kickback Safe Harbor Protection For Drug Rebates To Plans, PBMs
Article
27 Feb 2018
Analysis Of Medicare, Medicaid, And Other Health Policy Provisions In Bipartisan Budget Act
Article
28 Oct 2015
Proposed Budget Deal Would Add Medicaid Inflation Rebates For Generic Drugs
Article
03 Sep 2015
HRSA Publishes 340b Drug Pricing Program Omnibus Guidance Notice: Significant Policy Ramifications Should Trigger Public Comment
Article
20 Aug 2015
OIG Will Not Impose Sanctions On Entities For Program That Provides Free Drugs To Patients Experiencing Delayed Insurance Approvals
Article
24 Jun 2015
HRSA Issues 340B Drug Discount Program Civil Money Penalty Proposed Rule
Article
25 Sep 2014
HHS OIG Paints with Broad Brush in Criticizing Drug Manufacturer Coupon Programs
Article
22 May 2014
OIG Proposes Rule To Implement Expanded Civil Monetary Penalty Authority Under The ACA
Article
17 Mar 2014
Are Internal Compliance Investigations Privileged? D.C. District Court Rules No
Article
22 Mar 2013
ACA Affordable Insurance Exchanges and Qualified Health Plans*
Article
09 Jun 2011
IRS Extends To June 10 The Deadline For Submitting Error Reports On Branded Prescription Drug Sales
Article
16 May 2011
IRS Issues Guidance On The Dispute Resolution Process For The Preliminary Fee Calculation Of The 2011 Fee Imposed On Manufacturers And Importers Of Branded Prescription Drugs
Article
21 Dec 2010
IRS Issues Guidance on Calculation of the Annual Fee Imposed on Manufacturers and Importers of Branded Prescription Drugs Under the Affordable Care Act